Sussman MA, Volkers M, Fischer K, Bailey B, Cottage CT, Din S, et al
Staying hydrated is key
CrossRef Transarterial radioembolization versus atezolizumab-bevacizumab for the treatment of hepatocellular carcinoma with portal vein tumor thrombosis Youngsu Park, Yuri Cho, Seung Up Kim, Aryoung Kim, Hyunjae Shin, Hyo-Cheol Kim, In Joon Lee, Gyoung Min Kim, Dongho Hyun, Yunmi Ko, Jeayeon Park, Jae Woong Yoon, Gyung Sun Lim, Moon Haeng Hur, Yun Bin Lee, Eun Ju Cho, Jeong-Hoon Lee, Su Jong Yu, Jung-Hwan Diagnostic and Interventional Imaging .2026
For someone asking which is better in the mazdutide vs tirzepatide vs retatrutide comparison, the evidence currently supports the following conclusion: tirzepatide is the established treatment available today, mazdutide is an approved emerging alternative in China, and retatrutide is a potentially more powerful future option that still requires regulatory approval and additional safety evaluation